OKYO Pharma (OKYO) to Showcase Advances at Ophthalmology Futures Forum and ESCRS iNovation Day Amid Phase 3 NEPTUNE Trial Progress
OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical firm specializing in neuropathic corneal pain and anterior segment eye disorders, has revealed plans to present at two prominent European ophthalmology conferences in London on 10 and 11 September 2026. The co…
1 source
·2h ago